Vimarsana
Biggest News Aggregation in the World

Page 2 - Genomic Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genomic Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genomic Services Today - Breaking & Trending Today

UC San Francisco will be first hospital in California to offer pharmacogenetic testing - Vimarsana News

UC San Francisco will be first hospital in California to offer pharmacogenetic testing

Beginning May 9, UC San Francisco will be the first hospital in California, and one of only a few nationwide, to offer pharmacogenetic testing.

NGS-based RNA Sequencing Global Market to Reach $11.4 Billion by 2030: Rising Popularity and Demand for High Throughput Sequencing Methods Drives Growth - Vimarsana News

NGS-based RNA Sequencing Global Market to Reach $11.4 Billion by 2030: Rising Popularity and Demand for High Throughput Sequencing Methods Drives Growth

/PRNewswire/ -- The "Global NGS-based RNA Sequencing Market Size, Share, Trends, Product Type (Sequencing Instrument & Consumables, Sample Preparation, and...

Investegate |Yourgene Health PLC Announcements | Yourgene Health PLC: Proposed Capital Raising - Vimarsana News

Investegate |Yourgene Health PLC Announcements | Yourgene Health PLC: Proposed Capital Raising

Investegate announcements from Yourgene Health PLC, Proposed Capital Raising

The Healthcare Technology Report's Top 25 Women Leaders in Biotechnology of 2022 - Vimarsana News

The Healthcare Technology Report's Top 25 Women Leaders in Biotechnology of 2022

New York, NY (PRWEB) November 16, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Biotechnology of 2022. The

Source: prweb.com
Eremid® Genomic Services receives CLIA accreditation for its new clinical genomics laboratory - Vimarsana News

Eremid® Genomic Services receives CLIA accreditation for its new clinical genomics laboratory

Eremid® Genomic Services, LLC (“Eremid”) announces that it has been granted a Clinical Laboratory Improvement Amendments (CLIA) accreditation for its new laboratory dedicated to analyzing human clinical samples. Founded this year following acquisition by venture capital firm, Coddle Creek Capital (“CCC”), adding ...